Figure 1From: Neuroendocrine tumors of the pancreas: a retrospective single-center analysis using the ENETS TNM-classification and immunohistochemical markers for risk stratificationOverall survival and survival stratified for gender. The mean overall survival time was 92 ± 10 months and the 5-year overall survival rate was 63.9%. Women showed a significantly longer mean survival time compared to men (116 ± 9 versus 56 ± 14 months; P = 0.008).Back to article page